Medical Hypotheses
Volume 55, Issue 2 , Pages 93-98 , August 2000

Link between Helicobacter pylori infection and idiopathic parkinsonism

  • S.M. Dobbs

      Affiliations

    • Therapeutics in the Elderly, Research Group, Northwick Park & St Mark’s Hospitals, Harrow, UK
    • ,
  • R.J. Dobbs

      Affiliations

    • Therapeutics in the Elderly, Research Group, Northwick Park & St Mark’s Hospitals, Harrow, UK
    • ,
  • C. Weller

      Affiliations

    • Therapeutics in the Elderly, Research Group, Northwick Park & St Mark’s Hospitals, Harrow, UK
    • ,
  • A. Charlett

      Affiliations

    • Statistics Unit, Public Health Laboratory Service, London, UK

Received 12 January 2000 ,Accepted 28 February 2000.

References 

    REFERENCES
  1. Schwab RS. Symptomatology and medical treatment of Parkinson’s disease. Int J Neurol. 1961;2:61
  2. Strang RR. The association of gastro-duodenal ulceration with Parkinson’s disease. Med J Austr. 1965;52:842–843
  3. Glavin GB. Dopamine and gastroprotection. The Brain–Gut Axis. Dig Dis Sci. 1991;36:1670–1672
  4. Altschuler E. Gastric Helicobacter pylori infection as a cause of idiopathic Parkinson’s disease and non-arteric anterior optic ischemic neuropathy. Med Hypotheses. 1996;47:413–414
  5. Warren JR, Marshall B. Unidentified curved bacilli on gastric epithelium in active chronic gastritis. Lancet. 1983;i:1273–1275
  6. Charlett A, Dobbs RJ, Dobbs SM, Weller C, Brady P, Peterson DW. Parkinsonism: siblings share Helicobacter pylori seropositivity and facets of syndrome. Acta Neurol Scand. 1999;99:26–35
  7. Charlett A, Dobbs SM, Dobbs RJ, Weller C, Peterson DW. Differential age-trend in Helicobacter pylori antibodies and its anthropometric implications, in idiopathic parkinsonism. Gut. 1999;44:A67
  8. Kirollos C, O’Neill CJA, Dobbs RJ. Quantification of the cardinal signs of parkinsonism and of associated disability in spouses of sufferers. Age Ageing. 1993;22:20–26
  9. Tanner CM, Ottman R, Goldman SM. Parkinson disease in twins: an etiologic study. JAMA. 1999;281:376–378
  10. Di Tommaso A, Xiang Z, Bugnoli M. Helicobacter specific CD4+ T-cell clones from peripheral blood and gastric biopsies. Infection Immunity. 1995;63:1102–1106
  11. Fan XG, Yakoob J, Fan XJ, Keeling PW. Enhanced T-helper-2 lymphocyte responses: immune mechanism of Helicobacter pylori infection. Irish J Med Sci. 1996;165:37–39
  12. D’Elios MM, Manghetti M, De Carli M. T helper 1 effector cells specific for Helicobacter pylori in the gastric antrum of patients with peptic ulcer disease. J Immunol. 1997;158:962–967
  13. Haeberle HA, Kubin M, Bamford KB. Differential stimulation of interleukin-12 (IL-12) and IL-10 by live and killed Helicobacter pylori in vitro and association of IL-12 production with interferon gamma-producing T cells in human gastric mucosa. Infection Immunity. 1997;65:4229–4235
  14. Davies KN, King D, Billington JA, Barrett JA. Intestinal permeability and orocaecal transit time in elderly patients with Parkinson’s disease. Postgrad Med J. 1996;72:164–167
  15. Luzzi I, Pezzella C, Caprioli A, Covacci A, Bugnoli M, Censini S. Detection of vacuolating toxin of Helicobacter pylori in human faeces. Lancet. 1993;341:1348
  16. Edwards LL, Quigley EMM, Pfeiffer RF. Gastrointestinal dysfunction in Parkinson’s disease: frequency and pathophysiology. Neurology. 1992;42:726–732
  17. Singaram C, Ashraf W, Guamnitz EA. Dopaminergic defect of enteric nervous system in Parkinson’s disease patients with chronic constipation. Lancet. 1995;346:861–864
  18. Kuposky WJ, Grimes MM, Sweeting J, Bertsch R, Cote LJ. Parkinson’s disease and megacolon: concentric hyaline inclusions (Lewy bodies) in enteric ganglion cells. Neurology. 1987;37:1253–1255
  19. McGeer PI, Itagaki S, Boyes BE, McGeer EG. Reactive microglia are positive for HLA-DR in the substantia nigra of Parkinson’s and Alzheimer’s disease brains. Neurology. 1988;38:1285–1289
  20. Eisen A, Calne D. Amyotrophic lateral sclerosis, Parkinson’s disease and Alzheimer’s disease: phylogenetic disorders of the human neocortex sharing many characteristics. Can J Neurol Sci. 1992;19:117–123
  21. Boka G, Anglade P, Wallach D, Javoy-Agid F, Agid Y, Hirsch EC. Immunocytochemical analysis of tumour necrosis factor and its receptors in Parkinson’s disease. Neurosci Lett. 1994;172:151–154
  22. Mogi M, Harada M, Kondo T. Interleukin-1-beta, interleukin-6, epidermal growth-factor-alpha and transforming growth-factor-alpha are elevated in the brain from parkinsonian patients. Neurosci Lett. 1994;180:147–150
  23. Mogi M, Harada M, Narabayashi H, Ingaki H, Minami M, Nagatsu T. Interleukin (IL)-1 beta, IL-2, IL-4, IL-6 and transforming growth factor-alpha levels are elevated in ventricular cerebrospinal fluid in juvenile parkinsonism and Parkinson’s disease. Neurosci Lett. 1996;211:13–16
  24. Fiszer U, Mix E, Fredrikson S, Kostulas V, Link H. Parkinson’s disease and immunological abnormalities: increase of HLA-DR expression on monocytes in cerebrospinal fluid and of CD45RO+T cells in peripheral blood. Acta Neurol Scand. 1994;90:160–166
  25. Fiszer U, Mix E, Fredrikson S, Kostulas V, Olsson T, Link H. γδ+ T cells are increased in patients with Parkinson’s disease. J Neurol Sci. 1994;121:39–45
  26. Chiba S, Matsumoto H, Saitoh M, Kasahara M, Matsuya M, Kashiwagi M. A correlation study between serum adenosine-deaminase activities and peripheral lymphocyte subsets in Parkinson’s disease. J Neurol Sci. 1995;132:170–173
  27. Chiba M, Ishii N, Ishioka T. Topographic study of Helicobacter pylori and HLA-DR expression on gastric mucosa. J Gastroenterol. 1995;30:149–155
  28. Engstrand L, Scheynias A, Pählson C. An increased number of gamma/delta T-cells and gastric epithelial cell expression of the groEL stress-protein homologue in Helicobacter pylori -associated chronic gastritis of the antrum. Am J Gastroenterol. 1991;86:976
  29. Poupard A, Emile J. Autoimmunity in Parkinson’s disease. In:  Hassler RG,  Christ JF editor. Parkinson-specific Motor and Mental Disorders. Role of the Pallidum: Pathophysiological, Biochemical and Therapeutic Aspects.. New York: Raven Press; 1984;p. 307–313
  30. Dahlström A, Wigander A, Lundmark K, Gottfries C-G, Carvey PM, McRae A. Investigations on auto-antibodies in Alzheimer’s and Parkinson’s diseases, using defined neuronal cultures. J Neural Transm. 1990;29:195–206
  31. Fiszer U, Fredrikson S, Czlonkowska A. Humoral response to hsp 65 and hsp 70 in cerebrospinal fluid in Parkinson’s disease. J Neurol Sci. 1996;139:66–70
  32. Chen S, Le WD, Xie WJ. Experimental destruction of substantia nigra initiated by Parkinson disease immunoglobulins. Arch Neurol. 1998;55:1075–1080
  33. Calne DB, Eisen A, McGreer E, Spencer P. Parkinson’s disease, Alzheimer’s disease and motorneurone disease: abiotrophic interaction between ageing and environment?. Lancet. 1986;ii:1067–1070
  34. Koller WC. When does Parkinson’s disease begin?. Neurology. 1992;42:27–31
  35. Critchley M. The neurology of old age. Lancet. 1931;i:1221–1230
  36. Barbeau A. Aging and the extrapyramidal system. J Am Geriatr Soc. 1973;21:145–149
  37. Dobbs RJ, Lubel DD, Charlett A. Hypothesis: age-associated changes in gait represent, in part, a tendency towards parkinsonism. Age Ageing. 1992;21:221–225
  38. Kirollos C, Charlett A, O’Neill CJA. Objective measurement of activation of rigidity: diagnostic, pathogenetic and therapeutic implications in parkinsonism. Br J Clin Pharmacol. 1996;41:557–564
  39. Prettyman R. Extrapyramidal signs in cognitively intact elderly people. Age Ageing. 1998;27:557–560
  40. Dobbs RJ, Charlett A, Purkiss AG, Dobbs SM, Weller C, Peterson DW. Association of circulating TNF-α and IL-6 with ageing and parkinsonism. Acta Neurol Scand. 1999;100:34–41
  41. Ihan A, Krizman I, Ferlan-Marolt V, Tebez B, Gubina M. HLA-DR expression on CD8 lymphocytes from gastric mucosa in urease-positive and urease-negative gastritis. FEMS Immunol Med Microbiol. 1995;10:295–299
  42. Charlett A, Dobbs RJ, Purkiss AG. Cortisol is higher in parkinsonism and associated with gait deficit. Acta Neurol Scand. 1998;97:77–85
  43. Watkins AD. Perceptions, emotions and immunity: an integrated homeostatic network. Q J Med. 1995;88:283–294
  44. Rothwell NJ, Hopkins SJ. Cytokines and the nervous system II: actions and mechanisms of action. Trends Neurosci. 1995;18:130–136
  45. Male, D. Cooke, C. Owen, M. Trowsdale, J. Champion, B. Advanced Immunology. London, Mosby, 1996
  46. Ershler WB, Sun WH, Binkley N. The role if interleukin-6 in certain age-related diseases. Drugs Aging. 1994;5:358–365
  47. Dobbs RJ, Bowes SG, Charlett A. Hypothesis: the bradyphrenia of parkinsonism is a nosological entity. Acta Neurol Scand. 1993;87:255–261
  48. Dobbs RJ, Bowes SG, Henley M. Assessment of the bradyphrenia of parkinsonism: a novel use of delayed auditory feedback. Acta Neurol Scand. 1993;87:262–267
  49. Mortimer JA, Pirozzolo FJ, Hansch EC. Relationship of motor symptoms to intellectual deficits in Parkinson’s disease. Neurology. 1982;32:133–137
  50. Scott H, Rognum TO, Midtvedt T, Brandtzaeg P. Age-related changes of human serum antibodies to dietary and colonic bacterial antigens measured by enzyme-linked immunosorbent assay. Acta Path Microbiol Immunol Scand – Section C. 1985;93:65–70
  51. Birholz S, Knipp U, Opferkuch W. Stimulatory effects of Helicobacter pylori on human peripheral mononuclear cells of H. pylori infected patients and healthy blood donors. Zentrabl Bakteriol. 1993;280:166–176
  52. Norgaard A, Andersen LP, Elsborg L, Holck S, Nielsen H. Specific neutrophil hyporesponsiveness in chronic Helicobacter pylori infection. J Infect Dis. 1996;174:544–551
  53. Chmiela M, Lewala-Guruge JA, Wadstrom T, Rudnicka W. The stimulation and inhibition of T cell proliferation by Helicobacter pylori components. J Physiol Pharmcol. 1996;47:195–202
  54. Chmiela M, Paziak-Domanska B, Ljungh A, Wadstrom T, Rudnicka W. The proliferation of human T lymphocytes stimulated by Helicobacter pylori antigens. Immunobiol. 1996;195:199–208
  55. Negrini R, Lisato L, Zanella I. Helicobacter pylori infection induces antibodies cross-reacting with human gastric mucosa. Gastroenterology. 1991;101:437–445
  56. Appelmelk BJ, Negrini R, Moran AP, Kuipers EJ. Molecular mimicry between Helicobacter pylori and the host. Trends Microbiol. 1997;5:70–73
  57. Mathialogan R, Loizou S, Beales ILP. Who gets false-negative H. pylori (HP) ELISA results?. Gut. 1994;35:S51
  58. Charlett A, Dobbs RJ, Dobbs SM, Peterson DW, Weller C. Is Helicobacter pylori antigen responsible for changes in circulating immunoglobulin associated with ageing?. Br J Pharmacol. 1999;127:80P
  59. Charlett A, Dobbs RJ, Weller C, Dobbs SM, Peterson DW. Evidence for autoimmunity triggered by Helicobacter pylori in idiopathic parkinsonism. Br J Pharmacol. 2000;49:506P
  60. Kansau I, Labinge A. Heat shock proteins of Helicobacter pylori.. Aliment Pharmacol Ther. 1996;10:51–56
  61. Raine CS. Multiple sclerosis: immune system molecule expression in the central nervous system. J Neuropathol Exp Neurol. 1994;53:328–337
  62. Al-Janadi M, Al-Balla S, Al-Dalaan A, Raziuddin S. Cytokine production by helper T cell populations from the synovial fluid and blood in patients with rheumatoid arthritis. J Rheumatol. 1993;20:1647–1653
  63. Barton SGRG, Winrow VR, Rampton DS. Circulating antibodies to the 60-kD heat shock protein (hsp) family in patients with Helicobacter pylori infection. Clin Exp Immunol. 1998;112:490–494
  64. Parkinson, J. Essay on the Shaking Palsy. London, Sherwood, Neely & Jones, 1817
  65. Chen W, Shu D, Wilson IR, Tie A, Chadwick VS. Rapid elimination of Helicobacter pylori and reduction of histocompatibility leukocyte antigen-DR expression 12h after a single dose of omeprazole, amoxycillin and metronidazole triple therapy. J Gastroenterol Hepatol. 1999;14:322–327

PII: S0306-9877(00)91110-1

doi: 10.1054/mehy.2000.1110

Medical Hypotheses
Volume 55, Issue 2 , Pages 93-98 , August 2000

Article Tools